Cigna Group, adjusted total assets

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
As Reported
Total assets	155,881)	152,761)	143,932)	154,889)	155,451)
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)¹	—)	—)	—)	—)	—)
Less: Deferred tax assets (reported in Other assets)²	893)	1,055)	—)	—)	—)
After Adjustment
Adjusted total assets	154,988)	151,706)	143,932)	154,889)	155,451)

¹ Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

² Deferred tax assets (reported in Other assets). See details »

Download chart

Cigna Group, adjusted total liabilities

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
As Reported
Total liabilities	114,638)	106,410)	98,981)	107,705)	105,065)
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)¹	—)	—)	—)	—)	—)
Less: Deferred tax liabilities²	6,975)	7,242)	7,751)	8,346)	8,939)
After Adjustment
Adjusted total liabilities	107,663)	99,168)	91,230)	99,359)	96,126)

¹ Operating lease liability (before adoption of FASB Topic 842). See details »

² Deferred tax liabilities. See details »

Download chart

Cigna Group, adjusted shareholders’ equity

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
As Reported
Shareholders’ equity	41,033)	46,223)	44,872)	47,112)	50,321)
Adjustments
Less: Net deferred income tax assets (liabilities) per Consolidated Balance Sheets¹	(6,082)	(6,187)	(7,751)	(8,346)	(8,939)
Add: Redeemable noncontrolling interests	—)	107)	66)	54)	58)
Add: Other noncontrolling interests	210)	21)	13)	18)	7)
After Adjustment
Adjusted total equity	47,325)	52,538)	52,702)	55,530)	59,325)

¹ Net deferred income tax assets (liabilities) per Consolidated Balance Sheets. See details »

Download chart

Cigna Group, adjusted capitalization table

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
As Reported
Short-term debt	3,035)	2,775)	2,993)	2,545)	3,374)
Long-term debt	28,937)	28,155)	28,100)	31,125)	29,545)
Total reported debt	31,972)	30,930)	31,093)	33,670)	32,919)
Shareholders’ equity	41,033)	46,223)	44,872)	47,112)	50,321)
Total reported capital	73,005)	77,153)	75,965)	80,782)	83,240)
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)¹	—)	—)	—)	—)	—)
Add: Current operating lease liabilities (included in Accrued expenses and other liabilities)²	—)	105)	114)	159)	152)
Add: Operating lease liabilities (included in Other non-current liabilities)³	—)	340)	346)	436)	491)
Adjusted total debt	31,972)	31,375)	31,553)	34,265)	33,562)
Adjustments to Equity
Less: Net deferred income tax assets (liabilities) per Consolidated Balance Sheets⁴	(6,082)	(6,187)	(7,751)	(8,346)	(8,939)
Add: Redeemable noncontrolling interests	—)	107)	66)	54)	58)
Add: Other noncontrolling interests	210)	21)	13)	18)	7)
Adjusted total equity	47,325)	52,538)	52,702)	55,530)	59,325)
After Adjustment
Adjusted total capital	79,297)	83,913)	84,255)	89,795)	92,887)

¹ Operating lease liability (before adoption of FASB Topic 842). See details »

² Current operating lease liabilities (included in Accrued expenses and other liabilities). See details »

³ Operating lease liabilities (included in Other non-current liabilities). See details »

⁴ Net deferred income tax assets (liabilities) per Consolidated Balance Sheets. See details »

Download chart

Cigna Group, adjusted shareholders’ net income

US$ in millions

12 months ended:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
As Reported
Shareholders’ net income	3,434)	5,164)	6,668)	5,365)	8,458)
Adjustments
Add: Deferred income tax expense (benefit)¹	(95)	(1,659)	(480)	(220)	(386)
Add: Other comprehensive income (loss), net of tax	(477)	(206)	(513)	(37)	72)
Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest	344)	208)	76)	36)	23)
After Adjustment
Adjusted net income	3,206)	3,507)	5,751)	5,144)	8,167)

¹ Deferred income tax expense (benefit). See details »

Download chart

Cigna Group (NYSE:CI)

Adjustments to Financial Statements